Ezetimibe cost-effective option in statin intolerance

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.571, 2009-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Ezetimibe in Patients with Cardiovascular Disease and Statin Intolerance or Contraindications: A Markov Model

By Ara Roberta

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 6, 2008-01 ,pp. : 419-427

Adis International

Access to resources Recommend Favorite

Alteplase cost-effective option for acute ischaemic stroke

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 333, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

CRT a cost-effective option in Scandinavian settings

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 568, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Genetic screening for HCM a "highly cost-effective" option

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 602, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Eptifibatide cost-effective option for coronary interventions

Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite